Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,291 | 2 | 90.0% |
| Food and Beverage | $143.74 | 4 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Roche Diagnostics Corporation | $1,291 | 2 | $0 (2018) |
| Stemline Therapeutics Inc. | $66.58 | 1 | $0 (2019) |
| LEICA MICROSYSTEMS INC. | $65.31 | 2 | $0 (2018) |
| Celgene Corporation | $11.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $66.58 | 1 | Stemline Therapeutics Inc. ($66.58) |
| 2018 | $1,356 | 4 | Roche Diagnostics Corporation ($1,291) |
| 2017 | $11.85 | 1 | Celgene Corporation ($11.85) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2019 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $66.58 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2018 | LEICA MICROSYSTEMS INC. | IHC ISH ADVANCED STAINING - NON DIAGNOSTIC (Device) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 03/07/2018 | LEICA MICROSYSTEMS INC. | SPECIMEN INDENTIFICATION (Device) | Food and Beverage | In-kind items and services | $38.26 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 02/10/2018 | Roche Diagnostics Corporation | TD VENTANA Workflow Solutions (Device) | Travel and Lodging | In-kind items and services | $341.58 | General |
| Category: Tissue Diagnostics | ||||||
| 02/07/2018 | Roche Diagnostics Corporation | TD BenchMark Platforms (Device) | Travel and Lodging | In-kind items and services | $949.39 | General |
| Category: Tissue Diagnostics | ||||||
| 04/21/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Hematology / Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,491 | 2,659 | $328,837 | $76,763 |
| 2022 | 17 | 1,289 | 2,267 | $275,335 | $63,102 |
| 2021 | 21 | 1,796 | 3,080 | $381,391 | $93,808 |
| 2020 | 19 | 1,692 | 2,800 | $342,474 | $86,083 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 348 | 612 | $73,440 | $16,938 | 23.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 146 | 712 | $64,080 | $15,682 | 24.5% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 110 | 121 | $34,243 | $7,765 | 22.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 198 | 254 | $28,702 | $6,845 | 23.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 61 | 105 | $27,930 | $6,691 | 24.0% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 65 | 175 | $30,275 | $5,557 | 18.4% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 67 | 77 | $12,012 | $2,835 | 23.6% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 46 | 74 | $10,360 | $2,515 | 24.3% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 38 | 40 | $8,960 | $2,207 | 24.6% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 11 | 13 | $6,097 | $1,484 | 24.3% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 21 | 29 | $5,626 | $1,419 | 25.2% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 63 | 65 | $5,720 | $1,348 | 23.6% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 65 | 70 | $5,390 | $1,330 | 24.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 65 | 95 | $3,610 | $884.20 | 24.5% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 76 | 88 | $3,520 | $841.08 | 23.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 24 | 30 | $2,616 | $627.95 | 24.0% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 18 | 20 | $1,320 | $560.02 | 42.4% |
| 88364 | Genetic sequencing localization, each additional procedure | Facility | 2023 | 13 | 17 | $1,887 | $457.47 | 24.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 28 | 34 | $1,258 | $304.98 | 24.2% |
| 88141 | Pap test | Facility | 2023 | 15 | 15 | $855.00 | $240.24 | 28.1% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 13 | 13 | $936.00 | $229.71 | 24.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 353 | 714 | $85,680 | $19,238 | 22.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 124 | 531 | $47,790 | $11,548 | 24.2% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 73 | 100 | $26,600 | $6,415 | 24.1% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2022 | 82 | 93 | $26,319 | $5,957 | 22.6% |
About Dr. Simone Davion, M.D
Dr. Simone Davion, M.D is a Clinical Pathology healthcare provider based in Billings, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1497992275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simone Davion, M.D has received a total of $1,435 in payments from pharmaceutical and medical device companies, with $66.58 received in 2019. These payments were reported across 6 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($1,291).
As a Medicare-enrolled provider, Davion has provided services to 6,268 Medicare beneficiaries, totaling 10,806 services with total Medicare billing of $319,755. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology, Anatomic Pathology & Clinical Pathology
- Location Billings, MT
- Active Since 01/15/2009
- Last Updated 05/14/2025
- Taxonomy Code 207ZC0006X
- Entity Type Individual
- NPI Number 1497992275
Products in Payments
- TD BenchMark Platforms (Device) $949.39
- TD VENTANA Workflow Solutions (Device) $341.58
- ELZONRIS (Drug) $66.58
- SPECIMEN INDENTIFICATION (Device) $38.26
- IHC ISH ADVANCED STAINING - NON DIAGNOSTIC (Device) $27.05
- Revlimid (Drug) $11.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.